Abstract:Background: Cerebral ischemia-reperfusion injury (CIRI) usually occurs during the treatment phase of ischemic disease, which is closely related to high morbidity and mortality. Promoting neurogenesis and synaptic plasticity are effective neural recovery strategies for CIRI. Astragaloside IV (AS-IV) has been shown to play a neuroprotective role in some neurological diseases. In the current study, we evaluated the effect and possible mechanism of AS-IV in CIRI rats. Methods: The middle cerebral artery occlusion reperfusion (MCAO/R) model was established in rats to simulate the occurrence of human CIRI. First, we determined the cerebral injury on the 1st, 3rd, 5th and 7th day after cerebral ischemia-reperfusion (I/R) surgery by neurological deficit detection, TTC staining, TUNEL staining and Western blot analysis. Furthermore, rats were pre administered with AS-IV and then subjected to cerebral I/R surgery. Brains were collected on the 3rd day to evaluate the neuroprotective effect of AS-IV. Results: Our results showed that on the 3rd day after I/R, the neurological impairment score and infarct volume were highest, the levels of apoptosis and expression of Caspase3 and Bax reached the peak. AS-IV treatment apparently attenuated neurological dysfunction, reduced infarct volume and pathological damage, promoted the neurogenesis, and alleviated the pathological damage caused by cerebral I/R involved in thickening and blurring of synaptic membranes, reduction of microtubules and synaptic vesicles, and loss of synaptic cleft. Our study also showed that AS-IV promoted the transcription and expression of the peroxisome proliferators-activated receptors γ (PPARγ) and brain-derived neurotrophic factor (BDNF), increased the expression of phosphorylation of tyrosine kinase receptor B (TrkB) and downstream PI3K/Akt/mTOR pathway proteins. Notably, when GW9662, an inhibitor of PPARγ was administered with AS-IV, the neuroprotective effect of AS-IV was reduced. Conclusions: These findings suggested that AS-IV has neuroprotective function in CIRI rats, and its molecular mechanism may depend on the phosphatidylinositide 3-kinase (PI3K)/protein kinase B (PKB)/Akt signalling pathway activated by PPARγ. AS-IV could be an effective therapeutic drug candidate for CIRI treatment.

The Protective Effects of Apremilast Against Oxygen–Glucose Deprivation/Reperfusion (OGD/R)-Induced Inflammation and Apoptosis in Astroglia Mediated by CREB/BDNF

Protective Effect of Apigenin on Neurons Against Oxygen‐glucose Deprivation/reperfusion Induced Injury

The Neuroprotective Effect of Apigenin Against OGD/R Injury in Rat Hippocampal Neurons

Effect of the AMPK activator AICAR on inhibiting the inflammatory response of astrocytes and protecting the neurons from injury after oxygen-glucose deprivation treatment

Apremilast exerts protective effects on stroke outcomes and blood-brain barrier (BBB) dysfunction through regulating Rho-associated protein kinase 2 expression

Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats

Protective effects of Astragaloside IV against oxidative injury and apoptosis in cultured astrocytes by regulating Nrf2/JNK signaling

Edaravone Protects Against Oxygen-Glucose-Serum Deprivation/Restoration-Induced Apoptosis in Spinal Cord Astrocytes by Inhibiting Integrated Stress Response

Apigenin Mediated Protection of Ogd-Evoked Neuron-Like Injury in Differentiated Pc12 Cells

Total Saponins of Panax Notoginseng Modulate the Astrocyte Inflammatory Signaling Pathway and Attenuate Inflammatory Injury Induced by Oxygen- Glucose Deprivation/Reperfusion Injury in Rat Brain Microvascular Endothelial Cells

DOCOSAHEXAENOIC ACID PROTECTS RAT ASTROCYTES FROM OXYGEN-GRUCOSE DEPRIVATION/REPERFUSION INJURY BY ACTIVATING PPARγ AND DOWNSTREAM ANG/TIE2 AND PI3K/AKT SIGNALING PATHWAYS

[Recombinant Adiponectin Inhibits the Expression of Inflammation-Associated Proteins from Mouse Astrocytes Via AMPK-independent PKC Pathway].

Orexin-A alleviates astrocytic apoptosis and inflammation via inhibiting OX1R-mediated NF-κB and MAPK signaling pathways in cerebral ischemia/reperfusion injury

Protection Against Oxygen Glucose Deprivation Injury in Rat Astrocytes by Tetramethyphyrazine

Adiponectin Peptide Alleviates Oxidative Stress and NLRP3 Inflammasome Activation after Cerebral Ischemia-Reperfusion Injury by Regulating AMPK/GSK-3β

PPARα Inhibits Astrocyte Inflammation Activation by Restoring Autophagic Flux after Transient Brain Ischemia

Astragaloside IV plays a neuroprotective role by promoting PPARγ in cerebral ischemia-reperfusion rats

Adiponectin Protects against Glutamate-Induced Excitotoxicity via Activating SIRT1-Dependent PGC-1α Expression in HT22 Hippocampal Neurons

Dexmedetomidine inhibits apoptosis of astrocytes induced by oxygen-glucose deprivation via targeting JAK/STAT3 signal pathway

Apremilast ameliorates ox-LDL-induced endothelial dysfunction mediated by KLF6

Abstract WP124: Targeting Prodeath Signaling Upstream of Mitochondria Damage-cathepsins in Astrocytes Contributes to Neuroprotection Against Cerebral Ischmia